2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
Détails
Télécharger: 38458657.pdf (542.68 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_87AB27244127
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
Périodique
ESMO open
Collaborateur⸱rice⸱s
participants of the MASCC/ESMO Consensus Conference 2022. Electronic address: clinicalguidelines@esmo.org
ISSN
2059-7029 (Electronic)
ISSN-L
2059-7029
Statut éditorial
Publié
Date de publication
02/2024
Peer-reviewed
Oui
Volume
9
Numéro
2
Pages
102195
Langue
anglais
Notes
Publication types: Practice Guideline
Publication Status: ppublish
Publication Status: ppublish
Mots-clé
Humans, Vomiting/prevention & control, Vomiting/chemically induced, Nausea/prevention & control, Nausea/chemically induced, Radiation Oncology, MASCC–ESMO Clinical Practice Guideline, chemotherapy, nausea and vomiting, prevention, radiotherapy
Pubmed
Open Access
Oui
Création de la notice
14/03/2024 18:07
Dernière modification de la notice
15/03/2024 8:21